Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?

Benzinga_recent_news

2025/12/24

Indaptus Therapeutics Inc. (NASDAQ:INDP) jumped 64.65% to $3.26 in after-hours trading on Tuesday. Check out the current price of INDP stock here. Indaptus disclosed in a Form 8-K filing, which is ...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2593423587"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2593423587\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2593423587?lang=zh_CN&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/23/Stock-Market-Analysis--Notebooks--Laptop.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-12-24 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593423587","market":"hk","top_or_hot":-1,"title":"Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?","media":"Benzinga_recent_news","content":"<div>\n<p>Indaptus Therapeutics Inc. (NASDAQ:INDP) jumped 64.65% to $3.26 in after-hours trading on Tuesday.\nCheck out the current price of INDP stock here. \nIndaptus disclosed in a Form 8-K filing, which is ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading\">网页链接</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Did Indaptus Therapeutics Surge 64% In After-Hours Trading?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-24 11:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indaptus Therapeutics Inc. (NASDAQ:INDP) jumped 64.65% to $3.26 in after-hours trading on Tuesday.\nCheck out the current price of INDP stock here. \nIndaptus disclosed in a Form 8-K filing, which is ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading","article_id":"2593423587","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/23/Stock-Market-Analysis--Notebooks--Laptop.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2593423587","pubTimestamp":1766545920,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Indaptus Therapeutics surged 64.65% in after-hours trading following a major insider investment and board appointment.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","INDP":"Indaptus Therapeutics, Inc.","BK4007":"制药","LENZ":"Therapeutics","RSI":"Rush Street Interactive, Inc.","BK4539":"次新股","KALA":"KALA BIO","BK4150":"赌场与赌博"},"translate_title":"Indaptus Therapeutics为何在盘后交易中飙升64%？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KALA":1,"LENZ":1.5,"INDP":1,"RSI":1},"content_text":"Indaptus Therapeutics Inc. (NASDAQ:INDP) jumped 64.65% to $3.26 in after-hours trading on Tuesday.\nCheck out the current price of INDP stock here. \nIndaptus disclosed in a Form 8-K filing, which is used to report significant unscheduled corporate changes, that investor David E. Lazar purchased 300,000 shares of Series AA Preferred Stock and 700,000 shares of Series AAA Preferred Stock at $6.00 per share on Monday, generating aggregate gross proceeds of $6 million.\nThe preferred shares are convertible into 111 million shares of common stock, subject to stockholder approval.\nThe Board also appointed Lazar as Co-Chief Executive Officer. \nLazar currently serves as the CEO and Chairman of Kala Bio Inc. (NASDAQ:KALA). David previously served as Chief Executive Officer of Novabay Pharmaceuticals, Inc. (NASDAQ:NBY).\nAccording to Form 3 filings dated Tuesday, which insiders use to report their initial ownership of a company's securities, Lazar holds derivative securities convertible into 6 million common shares from Series AA Preferred Stock and 105 million shares from Series AAA Preferred Stock.\nAvraham Ben-Tzvi, who joined as a director, also reported ownership of 100 common shares held in a Roth Individual Retirement Account in a separate Form 3 filing.\nThe company also modified employment agreements with Jeffrey Meckler, Michael J. Newman, Nir Sassi, and Walt A. Linscott, providing equity settlements totaling 350,000 common shares and $4.4 million cash in exchange for 10-day notice periods and waived severance benefits.\nA special meeting will occur by March 31, 2026, to approve preferred conversion, authorize share increase, elect three Lazar designees, permit written consent actions, and authorize a reverse split.\nThe New York-based clinical-stage biotechnology company has a market capitalization of $3.47 million, a 52-week high of $47.60, and a 52-week low of $1.66.\nThe stock has struggled over the past year, falling 92.04%, reflecting significant challenges. This steep decline suggests that investors should be cautious, as short-term gains may not signal a lasting recovery.\nThe Relative Strength Index (RSI) of the stock stands at 36.65.\nIndaptus is close to its lows as it is currently only 0.7% higher than its 52-week low. This positioning implies that the stock is having trouble gaining traction and could continue to be under selling pressure until a major catalyst appears.\nPrice Action: INDP closed on Tuesday at $1.98, down 2.46%, according to Benzinga Pro data.\nBenzinga’s Edge Stock Rankings indicates INDP stock has a negative price trend across all time frames.  Track the performance of other players in this segment.\nPhoto Courtesy: boyphare on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}